[Study of urinary excretion of codeine and morphine after oral ingestion of codeine]. 1995

P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
Institut de Recherche Criminelle de la Gendarmerie, Rosny-sous-Bois.

Results of an investigation on the urinary excretion of codeine and morphine after oral ingestion of 1 mg.kg-1 b.w codeine are reported. The investigation run on seven clinically healthy subjects showed: low digestive absorption of codeine (# 20%); rapid biotransformation of codeine into morphine (first urines excreted after absorption); rapid disappearance of codeine from urines (#30 hrs); persistence of morphine alone (#68 hrs); rapid evolution of the codeine/morphine ratio (inversion of the ratio after #18 hrs); total elimination of morphine which can be greater than for codeine; very different half-life periods for codeine and morphine (5.1 and 13.6 hrs); no other codeine metabolites (nor-codeine and nor-morphine); very high individual variations; one subject with low activity of cytochrome P 450 dbl/buFL. Finally, in an epidemiological survey of drug addict behaviors and detection of drug addiction, it seems very difficult, may be even illusory and hazardous, to try and justify morphine found in urines (morphine, heroin, codeine, codethyline, pholcodine...) except in the very legitimate case where the ratio of urine concentrations of codeine and morphine is greater than one.

UI MeSH Term Description Entries
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D003061 Codeine An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough. Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-,Ardinex,Codeine Phosphate,Isocodeine,N-Methylmorphine,N Methylmorphine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1981, Beitrage zur gerichtlichen Medizin,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1963, Canadian journal of biochemistry and physiology,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1987, Journal of analytical toxicology,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 2004, Sudebno-meditsinskaia ekspertiza,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
March 2000, Journal of analytical toxicology,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1977, Bulletin on narcotics,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
April 1979, Annals of the Academy of Medicine, Singapore,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1991, Journal of analytical toxicology,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
January 1984, Journal of analytical toxicology,
P Lafargue, and H Benech, and P Chaminade, and E Chegaray, and C Pierard, and J F Campion, and M Henric-Resplandy
August 1990, Journal of clinical pharmacology,
Copied contents to your clipboard!